Benzinga | Mar 11, 2021 06:31AM EST

KalVista Pharmaceuticals Q3 EPS $(0.56) Down From $(0.52) YoY

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.56) per share. This is a 7.69 percent decrease over losses of $(0.52) per share from the same period last year.